SC
MBOT icon

Scotia Capital’s Microbot Medical MBOT Stock Holding History

Scotia Capital’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.2K Buy
32,876
+6,400
+24% +$14.3K ﹤0.01% 891
2025
Q4 		$53K Hold
26,476
– – ﹤0.01% 880
2025
Q3 		$80.8K Buy
26,476
+3,700
+16% +$11.5K ﹤0.01% 883
2025
Q2 		$57.4K Buy
22,776
+1
+0% +$2 ﹤0.01% 844
2025
Q1 		$34.4K Buy
22,775
+9,500
+72% +$16.8K ﹤0.01% 830
2024
Q4 		$14.9K Buy
+13,275
New +$13K ﹤0.01% 847

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Scotia Capital's MBOT Position: Q1 2026 in Review

Scotia Capital increased its Microbot Medical (MBOT) stake by 24% in Q1 2026, buying an estimated $14.3K and bringing the position to 32,876 shares worth $79.2K. The position accounts for ﹤0.01% of the portfolio, ranked #891.

Scotia Capital first reported a position in MBOT in Q4 2024 and has held it in 6 quarters since. The position peaked at $80.8K in Q3 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Scotia Capital held 32,876 shares of Microbot Medical worth $79.2K as of Q1 2026.
  • Scotia Capital bought 6,400 Microbot Medical shares in Q1 2026, an estimated $14.3K.
  • Microbot Medical made up ﹤0.01% of Scotia Capital's portfolio in Q1 2026, its #891 holding.
  • Scotia Capital first reported a position in Microbot Medical in Q4 2024 and has held it in 6 quarters since.
  • Scotia Capital's Microbot Medical position peaked at $80.8K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.